Seeing people make a difference is among the the great things about being linked to RxISK. One of those is Anne-Marie Kelly, celebrated here before, of whom more below. But first, Peter Selley.
Over the last two years and more but especially in the last 18 months, Peter has been working on RSV vaccines and making a difference.
It is Hard for Thee to Kick against the Pricks was the latest in a series of posts, which include the following and many others.
- The Once and Future Immunity
- Coming Clean on Neonatal Deaths
- For Every Matter under Heaven, there is a Season
I have worried at times how comprehensible some of the vaccine posts will be – they have a lot of detail. They should be in medical journals but we know the BMJ and other medical journals are scared to take articles from doctors – for legal liability reasons they want things written by journalists who will soft-pedal the wording. See Silencing Doctors and How the Safety of Drugs was Destroyed and Not the BMJ.
Unless you are equally in to vaccines, the density of detail risks losing people who are more likely to ask – what’s the big picture. This led to Embracing Healthcare’s Opportunities which attempted to give more people a feel for why these details matter. Since last week, another opportunity has opened up to get over a sense of the bigger picture.
Early on in the sequence of vaccine posts, in Shot in the Dark, Peter fingered Beate Kampmann, the first author on Pfizer’s key Abrysvo trial as someone who must know there was a serious problem with pre-term births and neonatal deaths with RSV maternal vaccines but who in presentations worked hard to allay fears there might be something going on – except possibly in some African countries.
Beate works in the London School for Hygiene and Tropical Medicine and Peter found out that LSHTM has applied to the Gates Foundation for funds on how to persuade South Africans and Kenyans that the vaccines were beneficial. He made a freedom of information request to get access to the grant application but LSHTM said no. He approached the Information Commissioner who instructed LHSTM to comply. They did and the grant paperwork shows Beate and colleagues stating RSV vaccines cause premature births and pre-exclampsia.
Kicking against the Pricks outlines how Moderna’s RSV and Covid vaccines for children have come a cropper. Peter who wrote to the ethics committee who approved a trial of Moderna’s mRNA RSV vaccine to point out that this trial clashed with Government RSV vaccine advice putting women who enter the trial in an awkward position. The Complaint Response shows his initial enquiry led to the trial being shut-down.
Given that Moderna are building factories in Britain to make these vaccines, making something like this happen at all and happen as quickly as it did is an achievement.
The Juggernaut is likely not derailed completely but this mess illustrates just how crazy the efforts to flood the last few weeks of pregnancy with vaccines are and how no-one has bothered either to stop and think or better again to introduce some rules into the game.
Juggernauts and Bureaucrats
Inspired by Anne-Marie’s efforts to get the alcohol inducing effects of SSRIs not just on the map but into Canadian Guidelines for alcohol use disorders Medical Triumph, Katinka Newman recently had this feature Antidepressants Turned me into a Raging Alcoholic published in the Daily Mail.
Antidepressants turned me into a raging alcoholic and I’m not alone: The little-known side-effect that ruins lives revealed by experts – plus who is most likely to suffer and what to do about it
By Katinka Blackford Newman For The Daily Mail Published: 11:50, 24 October 2024
High-flying lawyer, 33-year-old Tony Green was reluctant to ask for help from his GP when he developed depression during the pandemic.
But finding himself struggling with stress and panic attacks, he felt he had to do something.
And when his GP suggested he try antidepressants, he felt relieved that there seemed to be a simple solution.
But he had no idea that while the pills would alleviate his depression, they would also leave him with a drink problem.
Tony says that before he started taking the antidepressants, he was ‘a social drinker – so I wouldn’t drink on my own or just for the sake of it.
‘If I needed to drive somewhere after a social event, I could very easily not drink at all, or just have half a pint then nothing more. That’s not to say I never drank or had a night out, but I was always in control when I did.’
But that all changed when he started taking a form of antidepressant known as an SSRI – a selective serotonin reuptake inhibitor – in January 2021.
The decision would cost him his well-paid job as well as causing turmoil in his personal life.
Tony suffered from a little-known side-effect of SSRIs: they can turn some people with no history of alcoholic dependence into full-on alcoholics.
‘Taking an antidepressant caused me to develop an alcohol use disorder, which stripped me of my ability to control or stop my consumption of alcohol,’ he recalls.
‘It caused me to black-out after just a few pints and my behaviour changed to a scary degree.’
And Tony’s experience is far from unique.
‘With 15 per cent, or 8.6million, of the UK population now on antidepressants, SSRI-induced alcoholism is likely to be a relatively common problem yet is largely unrecognised,’ David Healy, a former professor of psychiatry at Bangor University says.
‘The consequences are that people drive their car drunk, they kill people, they end up in jail, they ruin other people’s lives – and they ruin their own life.’
In 2014, Professor Healy co-authored an article, called Ninety-three cases of alcohol dependence following SSRI treatment, in the International Journal of Risk and Safety in Medicine, after people contacted him (via the prescription drug safety website RxISK, which he runs), saying they’d developed an alcohol problem after taking the medication.
Five of these people have since died, at least four have lost their jobs and some ended up with criminal problems; the majority also reported that their drinking has cost them friendships, says Professor Healy.
Tony’s own experience began in the lockdown of January 2021.
‘It was cold and miserable and I was living on my own as my wife was working abroad,’ he says.
‘Work was stressful – there was a deal which meant I was working until midnight every night and at weekends. I started getting panic attacks and felt so isolated. I’d literally be lying on the floor crying because I was so stressed.’
After a 15-minute phone consultation with his GP, Tony was prescribed citalopram, an SSRI antidepressant.
It started to have an effect after six weeks, as he recalls: ‘I no longer had the panic attacks and all fear was gone and there was this constant positive drive to get things done.
‘I felt weirdly disinhibited. So at work I would go and hug people I’d never met. Looking back, I probably came across as very arrogant because I had no social inhibitions.
‘But at the time, I was very happy I had been given citalopram – if you’d asked me, I would have said it had saved my life.’
A few months later, in May 2021 with lockdown rules relaxed, Tony’s firm organised drinks at the pub.
When Tony looked on the NHS website to see if it was safe to drink alcohol while on antidepressants, he was reassured to find that the worst that could happen was that it could make you sleepy.
So Tony – who hadn’t drunk at all during lockdown, as ‘I didn’t like the idea of drinking on my own’ – joined his colleagues.
The last thing he remembers is drinking the third pint of beer.
‘Next thing I knew I woke up at home with a terrible hangover,’ he says.
‘When I looked at my bank statement I’d bought many rounds. The lads at work said I had got black-out drunk and passed out and someone had taken me home in a taxi.
‘To my horror, they said I’d been acting inappropriately by putting my arm around people and particularly putting my hand on a girl’s leg. I couldn’t believe it.
‘The last time I got drunk like that was 11 years previously during fresher’s week at university.’
Over the next few months, Tony’s drinking became more out-of-character.
At work lunches, if wine was ordered he felt ‘compelled to drink more and more’, whereas previously he’d only had a couple of glasses at most then stopped.
Tony says: ‘It became this insatiable desire to drink alcohol – it just tasted amazing to me.
If I went to my parents’ house to watch the football and have a beer, I’d be anxious we might run out.’
By now his wife was home again and commented on his drinking, ‘but I’d brush it off’, he says.
Tony says the cravings only happened once he drank alcohol – and for ‘a few days after’.
He admits he became ‘obsessed’ with alcohol, ‘as if it was the nectar of the gods’. ‘As well as drinking a lot, I was drunkenly buying rounds.’
Things came to a head six months later in November 2021 at another work drinks.
Worried he might get carried away again, his wife told him to be home by 9pm.
Tony recalls: ‘I wanted to go home but physically I couldn’t stop myself from drinking and
I got black-out drunk again. Apparently, I behaved inappropriately to the same girl whose leg I’d put my hand on in May, although I don’t remember anything about it.’
The following day, Tony was called in for a meeting with the HR department at work and was told the girl had made a complaint and the firm was taking disciplinary action.
By now Tony had begun to link his drinking with the citalopram.
‘My behaviour was totally out-of-character,’ he says.
‘Previously if I saw someone doing what I was doing I’d say ‘what the Hell is going on’?
The only thing that had changed was that I’d started taking citalopram.
‘I tried to tell them that at the disciplinary hearing, two months later in December 2021, but they didn’t believe me and I was fired for gross misconduct.’
Determined to prove that the antidepressant had caused his uncharacteristic behaviour, Tony began to investigate.
He looked online and found a number of people who had reported similar experiences, as well as academic papers linking SSRIs with increased alcohol consumption.
This included a 2014 paper in the International Journal of Risk and Safety Medicine, in which researchers looked at 200 cases of people who’d reported increased alcohol consumption as a result of taking SSRIs and concluded: ‘multiple lines of evidence amplify a thus far barely recognized signal of interactions of SSRI and related antidepressants with alcohol’.
Tony told his GP he thought the drug was causing his alcohol problem – ‘but he didn’t believe me and told me that alcohol addiction is common in people with depression’.
He says he lost faith in his GP and came off the drug without consulting him, two months later.
Within a week, his alcohol cravings had disappeared.
At a wedding soon after, he was delighted to find he’d lost interest in the open bar.
Tony says: ‘On citalopram, if I had a drink there would be this buzz, I’d feel incredible and I’d want another. All that stopped.’
There were other changes, too.
‘Once I’d stopped taking the drug I realised how abnormal I had become. I had this aggressive attitude and now I felt just normal again.’
The depression that had caused him to take the drug originally had also disappeared as lockdown was over, his wife was home and he no longer felt isolated.
Yet what had happened to him still rankled, so six months after coming off citalopram, Tony decided to run his own experiment to see whether being on the drug affected the levels of alcohol in his blood.
He used an industry-approved breathalyser, and made detailed notes and video recorded the process as he consumed two cans of beer on two different days – waiting an hour before recording his blood alcohol level, which he used as a baseline measurement.
He then began taking 20mg of citalopram every day, as before – and 16 days later ran the experiment again, four times over the course of the next two weeks.
He found that when taking the citalopram, an hour after drinking his blood alcohol levels were 40 per cent higher than when he wasn’t taking the drug.
To be sure of the results, he ran the test again a month after he’d stopped taking citalopram.
‘My blood alcohol levels returned to the baseline levels,’ he says. ‘I was amazed, it proved that on the citalopram, I wasn’t processing alcohol out of my body.’
From his research Tony learned that some people have a genetic variation that may increase their sensitivity to alcohol.
Keen to investigate further, he had a special gene test, involving a saliva swab test, with an online company – Myogenes – which showed he had a gene variation linked to alcohol dependence.
As Dr Stephanie Sharp, a pharmacologist at the Glasgow Expert Witness scheme, who specialises in the role our genes play in how we react to drugs, explains: ‘If this gene [known as SLC6A4] is faulty, there may already be an unusual amount of the mood boosting chemical serotonin in the brain.
‘When alcohol is added the result is euphoria – so the drive to drink alcohol is increased,’ she says.
SSRIs are designed to raise serotonin levels.
This knowledge has come at a heavy price for Tony, who feels that taking the medication ‘destroyed the career that I worked on for eight years as a lawyer’.
Although he counts himself lucky that his supportive wife and family accepted it might be caused by medication, he adds: ‘I feel too ashamed of my behaviour to speak with anyone at my old firm and that makes me angry, it feels unfair.’
He has now managed to get another job – and, although some details in his story have been changed to protect his anonymity, he’s keen to share his experience to stop it happening to others.
‘How many people are in prison, or have ruined their relationships because doctors aren’t aware of this and aren’t monitoring it?’ he asks.
Michael, 60, did end up in prison and is convinced that his life was wrecked by SSRI antidepressant-induced alcoholism.
A healthcare worker, he was 35 when he was prescribed the SSRI antidepressant Seroxat, after the death of his mother.
He’d never been depressed before and, like Tony, was only a moderate drinker.
Within a few weeks, his mood improved, so he began socialising with his friends.
But as soon as he had a drink, he had uncontrollable alcohol cravings he’d never experienced before.
‘I got banned from restaurants and bars and became an embarrassment to my friends,’ he says.
‘I got this craving for alcohol that was so intense I felt I was possessed. I’d continue drinking until I was either arrested for being drunk and disorderly or I collapsed into a coma,’ recalls Michael (not his real name).
His drinking also prompted other bizarre behaviour.
‘I had this compulsion to ring 999 as many as 20 or 30 times in the evenings,’ he admits.
He ended up serving six prison sentences – the longest being for six weeks – for nuisance calls and for being drunk and disorderly. As a result, he was sacked from his job after seven years on the pills.
Michael too began to wonder if the medication was causing his alcohol cravings, as nothing else had changed in his life.
Researching online he found others had experienced similar out-of-character cravings while taking SSRIs.
He appealed against some of his criminal convictions with evidence from medical experts, but failed because the judge said that the NHS website warned against drinking and taking antidepressants.
Michael says: ‘It seemed unfair because the NHS website only warns that you may become drowsy. It doesn’t say it can give you uncontrollable cravings.’
After ten years of taking Seroxat, he asked his GP to change his medication, and he was switched to another SSRI, citalopram.
This made no difference to his alcohol cravings so he decided to wean himself off the drug.
Immediately, the alcohol cravings reduced, but he had other withdrawal symptoms including mood swings, flu-like symptoms and panic attacks.
His GP then put him on mirtazapine, a type of antidepressant that doesn’t target the serotonin system in the same way as SSRIs – and his cravings for drink disappeared within days.
To his astonishment he also felt better in terms of his mood.
‘It was amazing to feel my emotions again – it was like a rebirth,’ says Michael. ‘Everything looked so beautiful – I remember crying again for the first time in years.’
After a couple of years, he tapered off the mirtazapine, because he wanted to feel ‘in control’ of his life and not on medication.
‘I barely touch drink now and I haven’t made a single call to the police or broken the law since,’ he says. ‘I lost the job I love in nursing and now work as a waiter. This has totally wrecked my life.’
Over the years, Professor Healy has been contacted by many people like Tony and Michael.
His research into the links between alcohol-use disorder and SSRIs – which includes a study published last year in the Canadian Medical Association Journal – has helped bring about a change in guidelines for these drugs in Canada.
This study, which he co-authored with two Canadian experts, makes ‘some pretty strong recommendations’ against treating people with alcohol problems with SSRIs, as well as emphasising the need to monitor ‘apparently recent-onset escalation in alcohol intake following SSRI therapy,’ he says.
It also highlights why, in Professor Healy’s view, the NHS website should now clearly state that SSRIs ‘can make people have uncharacteristic alcoholic cravings’.
Dr Danielle Middleton, deputy director of benefit/risk evaluation at the Medicines and Healthcare products Regulatory Agency (the government’s medicines regulator), told the Mail: ‘SSRI antidepressants are indicated for a range of mental health disorders including depression and anxiety, conditions which are themselves associated with an increased use of alcohol in some patients.
‘Like all effective medicines, SSRI antidepressants may be associated with side-effects, including feeling agitated, shaky or anxious especially early in treatment.
‘The patient leaflets for all SSRI antidepressants contain consistently clear warnings that patients should not drink alcohol whilst taking these medicines.
‘The Medicines and Healthcare products Regulatory Agency (MHRA) is aware of some evidence suggesting a potential association between SSRI antidepressant use and an increased desire to consume alcohol – and this evidence remains under review through routine safety monitoring of all SSRI antidepressant medicines.
‘If patients in the UK have experienced side-effects to their medication we encourage them to discuss their concerns with a healthcare professional. We also encourage them to submit a report to the MHRA’s Yellow Card scheme to help support ongoing monitoring of these medicines.’
Comments and Bureaucrats
The comments on the article were expected and disappointing. Many pointed out that the label for these drugs says don’t drink while on them. But the label doesn’t tell you why not to drink. Some doctors assume it is because you might be sedated – but the combination doesn’t sedate.
One reason is that as Anne-Marie demonstrated industry have known for a decade or more that SSRIs can cause alcoholism and have been developing drugs to try and make money out of doing the opposite that would let them claim a cure for alcohol problems. But saying don’t drink without telling us why not is no help at all. It is another example of industry and regulators Being Economical with the Truth – essentially Lying. – see The Prozac Era
Regulators like MHRA claim to be investigating the problem – and typically blame depression as the cause of the drinking – when they too know full well that SSRIs can cause alcoholism but they don’t want to deter you from getting put on these pills. They don’t want to deter you from getting drunk and driving a car and killing people. They don’t want to deter you from getting drunk and hanging yourself.
Regulators have the paperwork to show they have this under review for a decade or more – so it’s no skin off their nose. Give me paperwork I can hide behind and I can last any crisis out for ever.
Anne-Marie alone has done vastly more than all the world’s regulators combined to alert people to this serious problem.
The message for everyone else reading this post is that you too, like Peter and Anne-Marie can make a difference. Don’t stop throwing mud at the wall or slingshots at Goliath.
annie says
Amazing work from Peter Selley on RSV, and he was listened to – a great result.
Amazing work from Anne-Marie on SSRIs and Alcoholism.
Amazing work from Katinka Newman who has now had several articles published in the Daily Mail.
Katinka wrote the book The Pill That Steals Lives.
Katinka sends out a monthly newsletter to all her followers.
Some extracts:
October 2024
Join the Mailing List https://www.antidepressantrisks.org/stolen-lives
We’re pleased to announce the start of our Stolen Lives Recovery Support Group, which runs every Monday from 5pm – 6pm UK time on Zoom. We have already run a few meetings and the feedback has been very positive.
It is a space for those tapering off and withdrawing from psychiatric medication to talk about their experiences and give each other hope.
We welcome participants from anywhere in the world, at any stage of their prescription harm healing journey, and ask for a minimum donation of £10 to Antidepressant Risks per session. Please forward this on to anyone you think might be interested.
For details and to confirm your place, please email katinka@antidepressantrisks.org.
New article on SSRIs and alcoholism
This month an article I wrote about alcoholism caused by SSRIs was published in the Daily Mail. It revealed how SSRIs can cause people with no history of alcoholism to have uncontrollable cravings to drink, which went away as soon as they stopped the pills. When asked for a response, the MHRA replied that they recognise this problem and are reviewing data on this. I would love to hear from anyone who has personal experience of increased alcohol consumption as a result of taking SSRIs as I’m sure I can pitch a follow up article.
French film on the risks of antidepressants
I wanted to share the following short film about young people who have taken their own lives after being prescribed antidepressants, and features the Antidepressant Risks website. The two young men who appear in the video are Florian and Romain, who are sadly on our Stolen Lives page. You can read more about their stories here: antidepressantrisks.org/stolen-lives.
tim says
Outstanding, successful achievements by Dr. Peter Selley and Katinka Blackford Newman.
Greatly appreciated post.
Sincere thanks to both, and to RxISK.
mary H. says
Excellent post this morning. Such sad stories but worthy of being shared as much as possible. Could do with such instances pressed under the noses of all GPs. Getting them to share the possibility of such problems seems problematic – as is getting patients to read the PILs. However, whilst those remain with the ” may cause drowsiness if mixed with alcohol” clause and not much else, the reality will not become clear. Once you experience the reality of the possible consequences, the resulting devastation for both sufferer and friends and family become clear. They are life changing and can take years for the confidence of all to return to previous levels, as most concerned will see it merely as an “alcohol problem” without making that connection to the prescribed drug.
I find this sentence particularly interesting:- “Keen to investigate further, he had a special gene test, involving a saliva swab test, with an online company – Myogenes – which showed he had a gene variation linked to alcohol dependence.” Shane has recently completed a similar gene test – as far as I know, looking for any “medical” consideration of note (such as special care with doses of certain medications etc). – it will be interesting to see what comes back from that. It’s a shame that such tests are pricey as it surely would be interesting to have such results from many who find withdrawal difficult as well as having such specific problems as shared in this post.
This post is now on our “Feeling Blue?” Facebook group, in the hope that people will share it with their families and friends.
Dr. David Healy says
The genes angle is getting more complex. We apparently less and less think there is a gene for disorders and figure it is much more a case of interactions between our genes and the environment.
It is difficult to know what this means for gene testing – other than for ancestry. Watch this space.
D
Anne-Marie says
Thank you Katinka and Rxisk for all you do for us
The MHRA are shockingly bad at safe guarding people. Addiction in its self is a well known illness that can lead to serious health problems and death. If they seriously think an alcoholic can follow the “do not drink” warning sign there would be no need for medications to stop alcohol cravings in alcoholics in the first place. Why do they make drugs for alcoholics and alcoholic cravings?
Now onto ssri induced severe alcohol cravings in people who were not alcoholics before but recovered on stopping the ssri. It doesn’t take a rocket scientist to figure it out that ssris are acting on the same receptors that are used to stop alcohol cravings in a subgroup of alcoholics.
Ssris are causing alcoholism in a subgroup of non alcoholic people and exacerbating alcoholism in others.
The MHRA should be ashamed of themselves they are making people ill and putting them in danger by not warning them of a serious side effect that can happen to them.
They are not safe guarding patients at all. It’s a shoddy regulatory authority that’s only fit for the bin.
Makes my blood boil when you see the harms happening to people that could be avoided with proper warnings.
Johanna says
This is particularly important for people who are struggling to beat an alcohol addiction. And they are not being told — just the opposite, in fact.
Thirty years ago I was told by my doctors that there was little chance I could quit drinking until my “underlying depression” was adequately treated. After all, I was using the alcohol to “self-medicate,” wasn’t I? At the time I was already on my fourth or fifth antidepressant, but they were confident my alcoholism would be overcome … as soon as I found the “right” pill for my chemical imbalance.
What’s really depressing? Thirty-odd years later, people going for alcohol treatment are being told the same thing. I’ve met half-a-dozen people lately who are fresh out of medical treatment programs for alcoholism. All were placed on antidepressants, if they were not on them already. In at least some cases, I am sure, the meds are actively sabotaging their attempts to stay sober. At the very least, they don’t seem to be helping.
In this 2001 article from Slate, a tempermentally-shy writer recounts how Paxil introduced him to the joys of booze. Like most shy people, he had tried drinking to overcome that awkward feeling he always got at parties. It had never worked — until Paxil. Then it worked all too well. Ultimately he decided he’d rather go back to being shy:
https://slate.com/news-and-politics/2001/01/extroverted-like-me-how-a-month-and-a-half-on-paxil-taught-me-to-love-being-shy.html
Harriet Vogt says
‘For those like me who are fortunate enough to recover from the rage injustice flushes through our veins and make it through the red mists of righteous anger, the truths our experiences reveal are gifts.’
https://www.pslhub.org/learn/patient-engagement/patient-safety-partners/tom-bell-my-oodles-of-unwanted-experience-as-a-patient-safety-partner-r12318/
I read this piece today and thought of all of you – who contribute to the substance of Rxisk, pushing on to keep patients safe. Whilst the MHRA tasked with this role, specialises in squirmy PR detours around articulating obvious patient risks – for decades. Political change must be made to happen.
Congratulations to all for your work. And as for Peter’s direct hit on lies and dirty science – a remarkable achievement.
annie says
BY THE end of that week, I had been invited to join its expert panel to look at the effectiveness of the so-called ‘happy pills’, selective serotonin re-uptake inhibitors (SSRIs) —
But the panel wanted to kick the findings into the long grass
They appeared more interested in putting their reputations, and those of drugs companies, before the safety of patients.
Why I resigned over this disgraceful “happy pill” cover-up
by RICHARD BROOK
Daily Mail March 23 2004
CHIEF EXECUTIVE OF MIND
LAST week I resigned from the Government’s watchdog on anti-depressants after it tried to cover up its own ten-year failure to identify serious side-effects of the controversial drug Seroxat.
The Medicines and Healthcare Products Regulation Agency found from information that had been in its possession for more than a decade that high doses of the anti-depressant can lead to aggression and thoughts of suicide.
But instead of revealing the truth to the 17,000 people taking high doses and the other half-million Britons on a safer dose, the MHRA sat on its findings.
Astonishingly, I was actually threatened with legal action by Professor Kent Woods, chief executive of the MHRA, if I revealed this.
Mind, the mental health charity, has been tracking Seroxat for a decade and found it to be the most problematic anti-depressant. Side-effects include nervousness, aggression, irrational thoughts and, in some cases, feelings of suicide.
Although Seroxat has been effective for thousands suffering from severe depression, there are many who blame tragic events, including murders and suicide, on it.
Last year, BBC’s Panorama showed that — despite denials from the manufacturer — people can get hooked on Seroxat and suffer terrible withdrawal symptoms when trying to come off it.
The drug’s manufacturer, Glaxo-SmithKline, has sought to play down its side-effects, denying until last year that it could be addictive.
Mind — along with dozens of people suffering the drug’s side-effects — held a demonstration last June outside MHRA’s headquarters in London, calling for the drug regulator to take action.
BY THE end of that week, I had been invited to join its expert panel to look at the effectiveness of the so-called ‘happy pills’, selective serotonin re-uptake inhibitors (SSRIs) — drugs prescribed to tackle depression, anxiety and other psychological problems. They include Prozac and Seroxat.
I hoped we could issue clear guidance to doctors on how to prescribe SSRIs safely. But my colleagues at the regulator, all from the medical establishment — doctors, academics and psychiatrists — had different ideas.
They appeared more interested in putting their reputations, and those of drugs companies, before the safety of patients.
In October, the MHRA reviewed data from the earliest trials of Seroxat. The information was supplied by GlaxoSmithKline in the late Eighties, and it was the MHRA’s responsibility to analyse the statistics to inform its decisions.
In four reviews of these statistics over ten years, the regulator had failed to pick up the vital information that any dose of Seroxat above 20mg a day doesn’t work any better but significantly increases the side-effects. Some 17,000 people were prescribed more than 20mg of Seroxat last year.
But the panel wanted to kick the findings into the long grass, passing it to European regulators. It would take months. In that time, hundreds would be prescribed dangerous levels or Seroxat.
It was then that Professor Woods made clear I faced prosecution if I revealed what the regulator had found, citing the need to protect the ‘commercial confidentiality’ of drugs firms.
On the MHRA website, Professor Woods defends the watchdog, saying its advice is backed by clinical data.
A few days later, I went to see Health Minister Lord Warner to tell him of my concerns. He said he would speak to the regulator, and soon after they reluctantly published the findings.
Their statement ‘reminded’ doctors not to prescribe more than 20mg, as if it had been common practice all along. Previously, the MHRA’s recommended ‘safe’ dose was 20mg to 50mg a day.
I resigned. If a regulator will not own up to its mistakes, who knows if data about other drugs has not also been overlooked, with potentially fatal results.
Regulators are supposed to be a stop-check for safety issues. But at the MHRA, many of the people who work there or advise it have ties to drugs firms. Some have shares in the companies, research departments funded by them or receive fees for advice.
The only protection is a musical chairs system where you leave the room if you have an interest in the drug being discussed or its manufacturer, or you can stay but not vote.
THERE is an urgent need for an independent inquiry into the MHRA. The Government must also change its culture of secrecy.
Seroxat is far too extensively prescribed, especially for mild and moderate depression. But anti-depressants — including SSRIs — do work, and can prevent suicides in severe cases. However, they are not wonder drugs.
GPs should clearly outline all the options to sufferers and anti-depressants shouldn’t be the automatic answer. If vital information such as that the MHRA tried to cover up is not released, these decisions cannot be fully informed.
Likewise, patients on Seroxat concerned by my findings should consult their doctor before adjusting their medication.
Mind does a lot of work with the Government, and we have a good relationship. But I am very concerned that I was put under such pressure not to reveal the regulator’s findings.
My only hope in speaking out is that the regulator will change. It must listen to people suffering negative side-effects of drugs and to be more accountable to patients rather than to pharmaceutical companies.
Dr Alastair Benbow, European medical director at GlaxoSmithKline, says: ‘We remain fully confident in the effectiveness of Seroxat, an important medicine that has helped many millions around the world lead fuller lives.’ •